1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TINF2 CTRPv2 pan-cancer AAC -0.094 0.01
mRNA TMEM119 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA PTPRD CTRPv2 pan-cancer AAC -0.089 0.01
mRNA SARS CTRPv2 pan-cancer AAC -0.089 0.01
mRNA PSMD2 CTRPv2 pan-cancer AAC -0.096 0.01
mRNA EME1 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA IFT46 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA HOXB6 CTRPv2 pan-cancer AAC 0.11 0.01
mRNA DNAJC8 CTRPv2 pan-cancer AAC -0.095 0.01
mRNA RNASEL CTRPv2 pan-cancer AAC 0.096 0.01
Download CSV